CMO

 

Contract Manufacturing Service

The company's R&D team has more than ten years of experience in the total synthesis of natural compounds, Small melucule drugs, and has been deeply involved in the research and development of small molecule new drugs for decades. The management team members have worked in many well-known new drug R&D companies in China.

 

Zhejiang Hengkang Pharmaceutical Co., Ltd. Offer CMO(Contract Manufacturing) in small molecule drug. Hengkang Pharma has 160 reactors, totally 53000 L Volume, has hydrogenation reactor. Our site was approved by US FDA, EMA, NMPA, PDMA, KMDS.

15
18

16

17
21
19
20

Hengkang Pharma not only undertakes the conventional process reaction types, but also can provide you with:

  • Chiral asymmetric hydrogenation reaction
  • Total synthesis of natural compounds
  • Diazotization and its derivatization reaction (continuous flow technology)
  • Nitration reaction (continuous flow technology)
  • Oxidation reaction (continuous flow technology)
  • Hydrogenation reaction (continuous flow technology)
  • Cyclization reaction (continuous flow technology)
  • High viscosity reaction (continuous flow technology)
  • Amination reaction (continuous flow technology)
  • Selective monoacyl (ether) reaction (continuous flow technology)
  • Continuous flow design and industrialization services of traditional processes

 

CDMO

 

CDMO Business – Providing End-to-End One-stop Services

From early drug discovery to commercial production delivery, we provide customers with a one-stop solution through seamless integration of technology, resources, and processes.

1

8

7
10
p20260418143224e54bd
p20260418143225994d8
202604181440302488f
20260418144047b08b6

 

CRO

 

Our R&D center has a doctoral led R&D team from Peking University and Zhejiang University, with more than 70 R&D personnel, 100% of whom have a bachelor's degree or above. We provide a platform for the research and industrialization of active pharmaceutical ingredients and formulations, covering an area of over 6000 square meters and equipped with over 50 million imported instruments and equipment. We focus on the development of high-tech barriers to active pharmaceutical ingredient and formulation projects.

image001
image002
image003
image004
image005
image011
image012
image013
image014
image015
CDMOSERVICES

Dedicated to new drug R&D and the production of APIs and intermediates.

Contact now!